- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03075345
Acceptance and Commitment Therapy in the Treatment of Obesity: Pilot.
October 11, 2018 updated by: Sarah Wakefield, University of Sheffield
Testing the Added Benefit of Acceptance and Commitment Therapy (ACT) in the Treatment of Obesity: a Pilot Randomised Controlled Trial.
Obesity is an 'epidemic' within the UK.
Individuals living with obseity are at risk of developing cancer, heart problems and dieing.
Furthermore, obesity impacts on psychological wellbeing via lowered self-efficacy, self-esteem, body image and overall quality of life (QoL).
A pilot randomised controlled trial (RCT) is proposed to investigate the additional benefit of a psychological intervention alongside treatment as usual (TAU) in a weight management service.
Patients routinely attending an outpatient clinic will be randomised into TAU with or without additional acceptance and commitment Therapy (ACT) group based-input and their outcomes monitored over time.
Study Overview
Status
Withdrawn
Intervention / Treatment
Detailed Description
Overweight and obesity is reported as an 'epidemic' problem within the UK as well as the world.
Individuals living with this may be at higher risk of developing co-morbidities, such as cancers, heart problems or diabetes, and higher mortality rates are reported in this group.
Furthermore, overweight and obesity can also impact on a person's psychological wellbeing, such as their self-efficacy, self-esteem and body image as well as have a negative effect on their overall quality of life (QoL).
Therefore, a pilot randomised controlled trial (RCT) is proposed to investigate the additional benefit of a psychological intervention alongside treatment as usual (TAU) in a weight management service.
Patients routinely attending an outpatient clinic will be randomised into TAU with or without additional Acceptance and Commitment Therapy (ACT) group based-input.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sheffield, United Kingdom, S1 1HD
- University of Sheffield
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Individuals will be willing and able to give informed consent for participation in the study;
- Male or Female, aged 18 years or above.
- Individuals will have a Body Mass Index (BMI) of over 40 (or over 35 if they are from a black or other minority ethic (BME) group or have a co-existing physical health problem);
- Individuals will be on a waiting list for a weight loss management programme in the UK;
- Individuals will have English as a written language.
Exclusion Criteria:
- Individuals who are currently pregnant or breastfeeding;
- Individuals with current drug or alcohol abuse, such that would prevent them from engaging in a weight management programme;
- Individuals who are acutely mentally unwell, such that would prevent them from engaging in a weight management programme;
- Individuals who at time of referral are at significant risk to themselves of others, such that would prevent them from engaging in a weight management programme;
- Individuals who are acutely physically unwell and/or hospitalised, such that would prevent them from engaging in a weight management programme;
- Individuals who have a learning disability or cognitive impairment, such that would prevent them from engaging in a weight management programme.
- Currently in receipt of psychiatric services.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Treatment as usual (weight management intervention)
6 session weight management programme (over 12 weeks).
|
Six sessions of a dietetic intervention will be psychoeducational in nature around weight and nutrition, delivered by professionals working in the service.
|
|
EXPERIMENTAL: Treatment as usual plus acceptance and commitment therapy
6 session weight management programme (over 12 weeks) plus a 4 session acceptance and commitment therapy (ACT) programme.
The ACT part will commence straight after the conclusion of the weight management programme.
|
Six sessions of a dietetic intervention will be psychoeducational in nature around weight and nutrition, delivered by professionals working in the service.
Four sessions of the ACT protocol will be psychoeducational in nature, with brief experiential exercises in the class and in-between session practice.
It's aim is to allow individuals to be able to sit with difficult experiences (rather than fight against them) and in turn this may allow them to live towards what they value in life.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 7 days
|
A measure of psychological distress in relation to anxiety and depression symptoms.
There is a total of 14 items (7 items relate to anxiety; 7 items relate to depression) with answers scored on a Likert scale of 0-3 (scores from 0-42; higher scores indicating worse symptoms).
|
7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36)
Time Frame: 24 hours
|
The SF-36 is a generic measure of health related quality of life.
There is a total of 36 questions which can be grouped into 3 levels: i) 36 individual items; ii) 8 subscales; iii) 2 summary measures.
|
24 hours
|
|
Eating Self-Efficacy Scale (ESES)
Time Frame: 24 hours
|
It measures self-efficacy.
It contains 25-items measuring the person's confidence in ability to manage overeating in various situations (Likert scale 1-7 used).
|
24 hours
|
|
Action and Acceptance Questionnaire - II (AAQ-II)
Time Frame: 24 hours
|
The AAQ-II is a measure of experiential avoidance (i.e., attempts to alter difficult internal experiences which often leads to increased distress) and psychological inflexibility.
Patients are asked to rate their experiences on a 7-point Likert scale (from '1: never true' to '7: always true').
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
May 1, 2017
Primary Completion (ANTICIPATED)
October 1, 2017
Study Completion (ANTICIPATED)
January 1, 2018
Study Registration Dates
First Submitted
March 4, 2017
First Submitted That Met QC Criteria
March 4, 2017
First Posted (ACTUAL)
March 9, 2017
Study Record Updates
Last Update Posted (ACTUAL)
October 16, 2018
Last Update Submitted That Met QC Criteria
October 11, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 151261
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity, Acceptance and Commitment Therapy, Weight Management Service
-
Istanbul University - CerrahpasaRecruitingAcceptance and Commitment TherapyTurkey
-
Southern Methodist UniversityCompleted
-
University of AarhusRecruitingFocused Acceptance and Commitment Therapy (FACT) | WailistDenmark
-
The University of Hong KongNew Life Psychiatric Rehabilitation AssociationRecruitingAcceptance and Commitment Therapy | Psychological Well-beingHong Kong
-
University of Social Sciences and Humanities, WarsawNational Science Centre, PolandRecruitingHematopoietic Cell Transplantation Recipient | Acceptance and Commitment TherapyPoland
-
Region StockholmKarolinska Institutet; Forskningsrådet för hälsa, arbetsliv och välfärd (FORTE)RecruitingInternet-Delivered Psychological Treatments for Chronic Pain in Adolescents: ACT and Pain Education.Chronic Pain | Pain Management | Acceptance and Commitment Therapy | Cognitive Behavior Therapy | Nociplastic PainSweden
-
Western Michigan UniversityCompletedAcceptance and Commitment Therapy | Supportive Therapy
-
National Taiwan University HospitalRecruitingAcceptance and Commitment Therapy | Oncology Nurse | Psychological SupportTaiwan
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedPhysical Activity | Exercise | Behavior | Lifestyle | Acceptance and Commitment Therapy | ACT | Lifestyle, SedentaryUnited States
-
Necmettin Erbakan UniversityNot yet recruitingCaregiver Burden | Acceptance and Commitment Therapy | Pediatric Palliative CareTurkey (Türkiye)
Clinical Trials on Treatment as usual (dietetic intervention)
-
Kuopio University HospitalUniversity of Oslo; University of Eastern Finland; City of KuopioRecruiting
-
Indiana UniversityCompletedSchizophrenia | Schizoaffective Disorder | Schizophreniform DisorderUnited States
-
Sunnybrook Health Sciences CentreCompleted
-
Rhode Island HospitalCenters for Disease Control and PreventionRecruitingTeen Dating Violence | Aggression ChildhoodUnited States
-
Sorlandet Hospital HFSouth-Eastern Norway Regional Health AuthorityCompleted
-
Human Development Research Foundation, PakistanWorld Health Organization; University of Liverpool; WHO Collaborating Center...CompletedMaternal Behavior | Infant Behavior | Infant Development | Development Delay | Nutrition Poor | Perinatal Depression | Maternal Distress | Infant Malnutrition | Cognitive Developmental Delay | Motor Delay | Language Delay | Growth DelayPakistan
-
Gaia AGCompleted
-
Butler HospitalCompletedHIV | Bacterial InfectionUnited States
-
Columbia UniversityCompletedMultiple SclerosisUnited States
-
University of WashingtonNational Institute of Mental Health (NIMH)RecruitingSuicide PreventionUnited States